Navigation Links
Euro RSCG Life Broadens X2 Expertise
Date:9/5/2007

- Paul Velardi Joins Agency to Spearhead x2 Division -

NEW YORK, Sept. 5 /PRNewswire/ -- Euro RSCG Life, a leading healthcare communications network, announced that Paul Velardi has joined the firm as President of Euro RSCG Life x2. Euro RSCG Life x2 utilizes a strategic foundation in data combined with the strengths of multiple channels including consumer advertising, digital, managed care and medical education to provide clients with a comprehensive solution from a single company. Velardi reports directly to Douglas M. Burcin, Co-Chief Executive Officer of Euro RSCG Life North America.

"Paul is a strong addition to the already growing and diversified staff within Euro RSCG Life x2," said Doug Burcin, Co-CEO of Euro RSCG Life. "He brings many years of experience in direct marketing, CRM and digital-media application business which will be beneficial for this business unit."

With more than 20 years of agency experience, Velardi comes to Euro RSCG Life x2 from boost, inc., where he was Founder and President. He has worked with a diverse array of companies and/or brands such as Johnson & Johnson, Novartis, Time Inc., Continental Airlines, AT&T, AMEX, Dell, General Motors, HSBC and Crunch. His expertise includes solving client's marketing challenges, leading a team of professionals and partnering with numerous agencies from a wide array of marketing disciplines.

"I am thrilled to be leading such a talented and innovative agency and bringing a new, outside perspective," said Velardi. "Our goal is for Euro RSCG Life x2 to multiply expectations and to be a creative resource for account management by offering creative ways to leverage brand strategy across communication practices to deliver long-term growth for our clients' brands."

About Euro RSCG Life

Euro RSCG Life aligns the company's 44 health-focused offices in 22 countries. It creates a single network with almost 1,000 employees that offers clients comprehensive communications disciplines, including advertising, public relations, event promotion, medical education, interactive marketing and consulting services. The network's client roster includes GlaxoSmithKline, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough and Wyeth. Euro RSCG Life is part of Euro RSCG Worldwide, a leading integrated marketing communications agency that has been recognized as 2006 "Global Agency of the Year" by Advertising Age. Euro RSCG Worldwide is the largest unit of Havas, the world's fourth largest communications group.


'/>"/>
SOURCE Euro RSCG Life
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Roche offers HIV drug expertise to poor nations
2. Europe Seeks Indian Expertise
3. Half a Million Dollars Offered for GPs With Expertise in Anesthetics and Obstetrics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Olathe, KS (PRWEB) , ... April 28, 2017 ... ... system have typically been previously exposed to more adverse experiences than children in ... have experienced trauma such as abuse, neglect or other family challenges. While no ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... the Creator responds to and which He does not. Yisrayl says with so many ... is the true name, but he says with a little Scripture, backed with a lot ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that ... his presence to an educational purpose as the host of the “Informed” series. The ... In a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology: